OXR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.457800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.641000E-01
Normal-vs-Stage2
6.911800E-01
Normal-vs-Stage3
3.631000E-01
Normal-vs-Stage4
3.672200E-01
Stage1-vs-Stage2
9.890000E-01
Stage1-vs-Stage3
2.650600E-01
Stage1-vs-Stage4
4.785400E-01
Stage2-vs-Stage3
2.634800E-01
Stage2-vs-Stage4
3.477200E-01
Stage3-vs-Stage4
1.547980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.908400E-01
Normal-vs-AfricanAmerican
4.767000E-01
Normal-vs-Asian
7.268000E-01
Caucasian-vs-AfricanAmerican
5.742800E-01
Caucasian-vs-Asian
7.713800E-01
AfricanAmerican-vs-Asian
7.948400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.999400E-01
Normal-vs-Female
6.845400E-01
Male-vs-Female
5.947400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.037200E-01
Normal-vs-Age(41-60Yrs)
4.930800E-01
Normal-vs-Age(61-80Yrs)
8.816000E-01
Normal-vs-Age(81-100Yrs)
8.503800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.390000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.841800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.307800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.052300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.054600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.805200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.299200E-01
Normal-vs-Daily Drinker
9.704600E-01
Normal-vs-Weekly Drinker
9.265800E-01
Normal-vs-Occasional Drinker
5.113600E-01
Normal-vs-Social Drinker
7.968200E-01
Non Drinker-vs-Daily Drinker
7.606600E-01
Non Drinker-vs-Weekly Drinker
5.784000E-01
Non Drinker-vs-Occasional Drinker
2.308200E-01
Non Drinker-vs-Social Drinker
8.109400E-01
Daily Drinker-vs-Weekly Drinker
8.255200E-01
Daily Drinker-vs-Occasional Drinker
2.284800E-01
Daily Drinker-vs-Social Drinker
6.797600E-01
Weekly Drinker-vs-Occasional Drinker
1.963040E-01
Weekly Drinker-vs-Social Drinker
5.636400E-01
Occasional Drinker-vs-Social Drinker
4.924800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.030600E-01
Normal-vs-Grade 2
2.928300E-02
Normal-vs-Grade 3
5.810400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.596400E-03
Grade 1-vs-Grade 3
1.100090E-02
Grade 1-vs-Grade 4
2.030600E-01
Grade 2-vs-Grade 3
4.201800E-01
Grade 2-vs-Grade 4
2.928300E-02
Grade 3-vs-Grade 4
5.810400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.507600E-01
Normal-vs-NonDiabetic
7.943000E-01
Diabetic-vs-NonDiabetic
5.639600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.367400E-01
Normal-vs-NoPancreatitis
8.098400E-01
Pancreatitis-vs-NoPancreatitis
8.433400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.434400E-01
Normal-vs-N1
6.577400E-01
N0-vs-N1
5.339400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.759600E-02
Normal-vs-TP53-NonMutant
9.767400E-01
TP53-Mutant-vs-TP53-NonMutant
1.840890E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
